Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic pain conditions
3.2.1.2 Growing awareness of palliative care
3.2.1.3 Technological advancements in drug formulations
3.2.1.4 Rising number of surgical procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk of adverse effects and overdose
3.2.2.2 Concerns about opioid addiction and abuse
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Injectable
5.3 Oral
5.4 Other dosage forms
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Pain management
6.2.1 Cancer pain
6.2.2 Neuropathic pain
6.2.3 Osteoarthritis pain
6.2.4 Other pain managements
6.3 Palliative care
6.4 Diarrhea suppressant
6.5 Anesthesia
6.6 Cold & cough suppressant
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Ambulatory surgical centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Alcaliber S.A.
10.2 Daiichi Sankyo Company Limited
10.3 Hikma Pharmaceuticals PLC
10.4 Mallinckrodt plc
10.5 Pfizer Inc.
10.6 Purdue Pharma L.P.
10.7 Sandoz AG
10.8 Taj Pharmaceuticals Limited
10.9 Verve Health Care Ltd.
10.10 Viatris Inc.
